Contract Manufacturing of Nutritional Supplements & Vitamins
Technological Advantages
GeneIII’s technological edge lies in its unique research and development capabilities, including exclusive gene editing technology for strain construction and optimization. The company’s synthetic biology platform supports the efficient production of high-purity bioactive compounds, ensuring unrivaled quality and cost advantages.
Core Competencies
- Synthetic Biology Production and Research Platform: GeneIII has a state-of-the-art 1,000 sqm R&D base and a Class 10w clean raw material factory. The facility is equipped to support large-scale industrial production with high purity and yield.
- Patented Technologies: The company employs patented Bacillus Chromosome Editing Technology and Oscillating Gene Expression Regulation, enhancing product conversion rates and ensuring a stable, safe production process.
Key Ingredient: Ergothioneine (EGT)
Ergothioneine is a powerful antioxidant recognized for its cellular physiological protection functions. It has applications in various sectors, including cosmetics, food and health, and pharmaceuticals.
- Cosmetics Sector: EGT is a high-value skincare ingredient that combats aging by brightening skin, improving dullness, and diminishing fine lines.
- Food and Health Sector: EGT, when ingested, can treat conditions like cancer and cardiovascular diseases, and when applied topically, it can treat skin and inflammatory diseases.
- Pharmaceutical Sector: EGT supports brain health, enhances cognitive function, and promotes overall metabolism and immune function.
Manufacturing Standards
GeneIII’s production plant adheres to C-GMP requirements, ensuring compliance with international quality standards (CP/USP/EP/JP). The facility is equipped with advanced testing equipment to maintain high-quality production standards.
Research and Development
The company’s commitment to R&D is evident from its investment strategy, with 80% of funds allocated to research. The professional research team, comprising over 60 personnel, includes 3 industry Ph.D. holders, ensuring continuous innovation and improvement.
Conclusion
GeneIII’s capabilities in contract manufacturing for nutritional supplements and vitamins are underpinned by its robust synthetic biology platform, patented technologies, and commitment to high-quality production. The company’s expertise in producing bioactive compounds like Ergothioneine positions it as a leader in the industry, offering unparalleled products and services to enhance human health and beauty.